Alvotech ALVO
NASDAQ ALVO
$5.32 -0.06 (-1.12%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alvotech (ALVO) Cost of Revenue (2022 - 2026)

Alvotech's (ALVO) quarterly Cost of Revenue came in at $52.2 million in Q2 2026, down 29.3% on a YoY basis from $73.8 million in Q2 2025, and up 13.26% quarter-over-quarter from $46.1 million in Q1 2026.

Analysis

Alvotech (ALVO) Cost of Revenue (2022 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Cost of Revenue for 5 consecutive years, with $52.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cost of Revenue fell 29.3% year-over-year to $52.2 million; the trailing twelve-month figure through Jun 2026 stood at $272.6 million (down 25.2% YoY), and the FY2025 full-year result was $235.6 million, up 27.12% from the prior year.
  • Cost of Revenue improved to $52.2 million in Q2 2026 per ALVO's latest filing, from $46.1 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $185.3 million in Q4 2024 and bottomed at -$46.3 million in Q2 2022.
  • Historically, Cost of Revenue has averaged $67.8 million across 5 years, with a median of $58.1 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Cost of Revenue surged 281.23% in 2023, then slumped 87.59% in 2024.
  • Over 5 years, Cost of Revenue stood at $64.1 million in 2022, then surged by 150.96% to $160.9 million in 2023, then gained by 15.2% to $185.3 million in 2024, then decreased by 24.84% to $139.3 million in 2025, then plunged by 62.52% to $52.2 million in 2026.
  • According to Business Quant data, Cost of Revenue over the past three periods registered $52.2 million, $46.1 million, and $139.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 1.99 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 2.30 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 455.94 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 461.69 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 753.00 Mn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 100.16 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 52.20 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 90.43 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 721,000.00
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00 255,640.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.20 Mn
Mar 31, 2026 46.09 Mn
Dec 31, 2025 139.27 Mn
Sep 30, 2025 35.01 Mn
Jun 30, 2025 73.83 Mn
Mar 31, 2025 65.45 Mn
Dec 31, 2024 185.31 Mn
Sep 30, 2024 39.81 Mn
Jun 30, 2024 45.21 Mn
Mar 31, 2024 19.96 Mn
Dec 31, 2023 160.86 Mn
Aug 31, 2023 67.91 Mn
Jun 30, 2023 28.81 Mn
Mar 20, 2023 160.86 Mn
Dec 31, 2022 64.10 Mn
Aug 31, 2022 17.81 Mn
Jun 30, 2022 -46.28 Mn
Mar 20, 2022 64.10 Mn